Immunovant, Inc. - stock earnings
IMVT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -51.4 million USD | ? USD |
| 2023Q3 | -58.7 million USD | ? USD |
| 2023Q2 | -73.9 million USD | ? USD |
| 2023Q1 | -59.4 million USD | ? USD |
| 2022Q4 | -63.2 million USD | ? USD |
| 2022Q3 | -47.9 million USD | ? USD |
| 2022Q2 | -40.4 million USD | ? USD |
| 2022Q1 | -47.2 million USD | ? USD |
| 2021Q4 | -41.4 million USD | ? USD |
| 2021Q3 | -37.7 million USD | ? USD |
| 2021Q2 | -30.5 million USD | ? USD |
| 2021Q1 | -28.2 million USD | ? USD |
| 2020Q4 | -31.8 million USD | ? USD |
| 2020Q3 | -20.8 million USD | ? USD |
| 2020Q2 | -26.7 million USD | ? USD |
| 2020Q1 | -20.6 million USD | ? USD |
| 2019Q4 | -11.3 million USD | ? USD |
| 2019Q3 | 125090 USD | ? USD |
| 2019Q2 | 182749 USD | ? USD |
| 2019Q1 | -450 USD | ? USD |
| 2018Q4 | -8.8 million USD | ? USD |
| 2018Q3 | -6.3 million USD | ? USD |
| 2018Q2 | -4.4 million USD | ? USD |
IMVT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -211.0 million USD | ? USD |
| 2022 | -156.7 million USD | ? USD |
| 2021 | -107.4 million USD | ? USD |
| 2020 | -66.4 million USD | ? USD |
| 2019 | -450 USD | ? USD |
| 2018 | -136.7 million USD | ? USD |
IMVT
Price: $28.86
52 week price:
Earnings Per Share: -1.81 USD
P/E Ratio: -17.82
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 791496
Market Capitalization: 4.2 billion